LAVAL, Quebec, July 15, 2016 /PRNewswire/ -- Valeant
Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today
announced that it plans to host a conference call and live webcast
on August 9, 2016 to discuss second
quarter 2016 financial results.
Conference Call Details:
|
Date
|
Tuesday, August 9,
2016
|
|
Time
|
8:00 a.m.
ET
|
|
Webcast
|
http://ir.valeant.com/events-and-presentations
|
|
Participant Event
Dial-in
|
(877) 876-8393 (North
America)
|
|
(973) 200-3961
(International)
|
|
Participant
Passcode
|
48835456
|
|
Replay
Dial-in
|
(855) 859-2056 (North
America)
|
|
(404) 537-3406
(International)
|
|
Replay
Passcode
|
48835456 (Replay
available until August 17, 2016)
|
About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a
multinational specialty pharmaceutical company that develops,
manufactures and markets a broad range of pharmaceutical products
primarily in the areas of dermatology, gastrointestinal disorders,
eye health, neurology and branded generics. More information about
Valeant can be found at www.valeant.com.
Contact Information:
Laurie W.
Little
laurie.little@valeant.com
or
Elif McDonald
elif.mcdonald@valeant.com
514-856-3855
877-281-6642 (toll free)
Media:
Renée Soto
or
Chris Kittredge/Jared Levy
Sard Verbinnen & Co.
212-687-8080
Logo -
http://photos.prnewswire.com/prnh/20101025/LA87217LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/valeant-pharmaceuticals-announces-second-quarter-results-conference-call-date-and-details-300299291.html
SOURCE Valeant Pharmaceuticals International, Inc.